SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CME Group Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Wednesday, 2/28/24, at 3:24pm ET   ·   For:  12/31/23   ·   Accession #:  1156375-24-10   ·   File #:  1-31553

Previous ‘10-K’:  ‘10-K’ on 2/27/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   24 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/28/24  CME Group Inc.                    10-K       12/31/23  107:11M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.20M 
 2: EX-10.5     Amendment to Supplemental Deferred Savings Plan     HTML     34K 
 3: EX-21.1     List of Subsidiaries of Cme Group Inc               HTML     38K 
 4: EX-23.1     Consent of Ernst & Young LLP                        HTML     31K 
 8: EX-97.1     Compensation Recoupment Policy                      HTML     40K 
 5: EX-31.1     Section 302 Certification                           HTML     32K 
 6: EX-31.2     Section 302 Certification                           HTML     32K 
 7: EX-32.1     Certification Pursuant to U.S.C. Section 1350       HTML     31K 
14: R1          Cover Page                                          HTML    106K 
15: R2          Auditor Information                                 HTML     33K 
16: R3          Consolidated Balance Sheets                         HTML    135K 
17: R4          Consolidated Statements of Income                   HTML    131K 
18: R5          Consolidated Statements of Comprehensive Income     HTML     97K 
19: R6          Consolidated Statements of Shareholders' Equity     HTML    142K 
20: R7          Consolidated Statements of Shareholders' Equity     HTML     32K 
                Equity Statement Parentheticals                                  
21: R8          Consolidated Statements of Cash Flows               HTML    152K 
22: R9          CONSOLIDATED BALANCE SHEETS Parentheticals          HTML     70K 
23: R10         Organization and Business                           HTML     33K 
24: R11         Summary of Significant Accounting Policies          HTML     59K 
25: R12         Revenue Recognition Revenue Recognition (Notes)     HTML     71K 
26: R13         Performance Bonds and Guaranty Fund Contributions   HTML     67K 
27: R14         Property                                            HTML     43K 
28: R15         Intangible Assets and Goodwill                      HTML     91K 
29: R16         Long-term Investments                               HTML     35K 
30: R17         Debt                                                HTML     55K 
31: R18         Income Taxes                                        HTML    113K 
32: R19         Employee Benefit Plans                              HTML    112K 
33: R20         Commitments                                         HTML     83K 
34: R21         Contingencies                                       HTML     35K 
35: R22         Guarantees                                          HTML     34K 
36: R23         Capital Stock                                       HTML     47K 
37: R24         Stock-Based Payments                                HTML     48K 
38: R25         Accumulated Other Comprehensive Income (Loss)       HTML     91K 
39: R26         Fair Value Measurements                             HTML     81K 
40: R27         Earnings Per Share                                  HTML     56K 
41: R28         Subsequent Events                                   HTML     31K 
42: R29         Schedule II?Valuation and Qualifying Accounts       HTML     49K 
43: R30         Summary of Significant Accounting Policies          HTML    107K 
                (Policy)                                                         
44: R31         Revenue Recognition (Tables)                        HTML     62K 
45: R32         Performance Bonds and Guaranty Fund Contributions   HTML     54K 
                (Tables)                                                         
46: R33         Property (Tables)                                   HTML     42K 
47: R34         Intangible Assets and Goodwill (Tables)             HTML     71K 
48: R35         Intangible Assets and Goodwill Goodwill (Tables)    HTML     58K 
49: R36         Debt (Tables)                                       HTML     59K 
50: R37         Income Taxes (Tables)                               HTML    118K 
51: R38         Employee Benefit Plans (Tables)                     HTML    110K 
52: R39         Commitments (Tables)                                HTML     94K 
53: R40         Capital Stock (Tables)                              HTML     43K 
54: R41         Stock-Based Payments (Tables)                       HTML     45K 
55: R42         Accumulated Other Comprehensive Income (Loss)       HTML     90K 
                (Tables)                                                         
56: R43         Fair Value Measurements (Tables)                    HTML     76K 
57: R44         Earnings Per Share (Tables)                         HTML     56K 
58: R45         Summary of Significant Accounting Policies          HTML     46K 
                (Narrative) (Details)                                            
59: R46         Revenue Recognition (Details)                       HTML     70K 
60: R47         Performance Bonds and Guaranty Fund Contributions   HTML     52K 
                (Narrative) (Details)                                            
61: R48         Performance Bonds and Guaranty Fund Contributions   HTML     41K 
                (Cash and Securities Held as Performance Bonds and               
                Guaranty Fund Contributions at Fair Value)                       
                (Details)                                                        
62: R49         Performance Bonds and Guaranty Fund Contributions   HTML     32K 
                (Performance Bond Deposits and Security Deposits)                
                (Details)                                                        
63: R50         Property (Details)                                  HTML     60K 
64: R51         Intangible Assets and Goodwill (Narrative)          HTML     32K 
                (Details)                                                        
65: R52         Intangible Assets and Goodwill (Components of       HTML     49K 
                Intangible Assets) (Details)                                     
66: R53         Intangible Assets and Goodwill Intangible Assets    HTML     41K 
                and Goodwill (Useful Lives of Intangible Assets)                 
                (Details)                                                        
67: R54         Intangible Assets and Goodwill (Future Estimated    HTML     42K 
                Amortization Expense) (Details)                                  
68: R55         Intangible Assets and Goodwill Intangible Assets    HTML     49K 
                and Goodwill (Components of Goodwill) (Details)                  
69: R56         Long-Term Investments (Details)                     HTML     50K 
70: R57         Debt (Schedule of Short-Term and Long-Term Debt)    HTML     71K 
                (Details)                                                        
71: R58         Debt (Long-Term Debt Maturities at Par Value)       HTML     45K 
                (Details)                                                        
72: R59         Income Taxes (Income Tax Provision) (Details)       HTML     65K 
73: R60         Income Taxes (Federal Income Tax Rate) (Details)    HTML     46K 
74: R61         Income Taxes (Deferred Tax Assets (Liabilities) )   HTML     51K 
                (Details)                                                        
75: R62         Income Taxes (Summary Of Unrecognized Tax           HTML     37K 
                Benefits) (Details)                                              
76: R63         Income Taxes (Reconciliation Of Unrecognized Tax    HTML     43K 
                Benefits) (Details)                                              
77: R64         Income Taxes Income Taxes (Narrative) (Details)     HTML     33K 
78: R65         Employee Benefit Plans (Narrative) (Details)        HTML     62K 
79: R66         Employee Benefit Plans (Summary of the change in    HTML     47K 
                projected benefit obligation) (Details)                          
80: R67         Employee Benefit Plans (Change in Plan Assets)      HTML     39K 
                (Details)                                                        
81: R68         Employee Benefit Plans (Fair Value of Plan Assets)  HTML     47K 
                (Details)                                                        
82: R69         Employee Benefit Plans (Components of Net Pension   HTML     67K 
                Expense) (Details)                                               
83: R70         Employee Benefit Plans (Accumulated Other           HTML     41K 
                Comprehensive Income (Loss), of the Prior Service                
                Costs and Actuarial Losses) (Details)                            
84: R71         Employee Benefit Plans (Anticipated Benefit         HTML     40K 
                Payments from the Plan in Future Years) (Details)                
85: R72         Leases and Other Commitments (Narrative) (Details)  HTML     49K 
86: R73         Leases and Other Commitments Lease Costs (Details)  HTML     43K 
87: R74         Leases and Other Commitments Supplemental Cash      HTML     33K 
                Flow Information-Leases (Details)                                
88: R75         Leases and Other Commitments Supplemental Balance   HTML     51K 
                Sheet Information-Leases (Details)                               
89: R76         Leases and Other Commitments Operating Leases       HTML     48K 
                Future Minimum Payments Due (Details)                            
90: R77         Leases and Other Commitments Capital Lease Future   HTML     49K 
                Minimum Payments (Details)                                       
91: R78         Guarantees (Details)                                HTML     42K 
92: R79         Capital Stock (Narrative) (Details)                 HTML     54K 
93: R80         Capital Stock (Capital stock) (Details)             HTML     56K 
94: R81         Stock-Based Payments (Narrative) (Details)          HTML     75K 
95: R82         Stock-Based Payments (Compensation Expense And      HTML     41K 
                Income Tax Benefit Recognized) (Details)                         
96: R83         Stock-Based Payments (Restricted Stock Activity)    HTML     52K 
                (Details)                                                        
97: R84         Accumulated Other Comprehensive Income (Loss)       HTML     76K 
                (Schedule of Accumulated Other Comprehensive                     
                Income) (Details)                                                
98: R85         Fair Value Measurements (Financial Instruments      HTML     66K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
99: R86         Fair Value Measurements (Debt Instruments)          HTML     48K 
                (Details)                                                        
100: R87         Fair Value Measurements (Narrative) (Details)       HTML     33K  
101: R88         Earnings Per Share (Basic and Diluted Earnings Per  HTML     89K  
                Share) (Details)                                                 
102: R89         Schedule II?Valuation and Qualifying Accounts       HTML     41K  
                Schedule II?Valuation and Qualifying Accounts                    
                (Details)                                                        
104: XML         IDEA XML File -- Filing Summary                      XML    197K  
107: XML         XBRL Instance -- cme-20231231_htm                    XML   2.54M  
103: EXCEL       IDEA Workbook of Financial Report Info              XLSX    191K  
10: EX-101.CAL  XBRL Calculations -- cme-20231231_cal                XML    210K 
11: EX-101.DEF  XBRL Definitions -- cme-20231231_def                 XML   1.16M 
12: EX-101.LAB  XBRL Labels -- cme-20231231_lab                      XML   2.13M 
13: EX-101.PRE  XBRL Presentations -- cme-20231231_pre               XML   1.43M 
 9: EX-101.SCH  XBRL Schema -- cme-20231231                          XSD    210K 
105: JSON        XBRL Instance as JSON Data -- MetaLinks              634±   950K  
106: ZIP         XBRL Zipped Folder -- 0001156375-24-000010-xbrl      Zip    613K  


‘EX-97.1’   —   Compensation Recoupment Policy


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  
EXHIBIT 97.1
CME GROUP INC.
COMPENSATION RECOUPMENT POLICY
FOR EXECUTIVE OFFICERS

The Compensation Committee (“Committee”) of the Board of Directors of CME Group Inc. (the “Company”) adopts this Compensation Recoupment Policy for Executive Officers (“Policy”) effective as of October 2, 2023 (“Effective Date”). This Policy is designed to comply with Section 10D of the Securities Exchange Act of 1934, as amended (“Exchange Act”).
1.Definitions
For purposes of this Policy, the following definitions shall apply:
a)Covered Compensation” means any Incentive-Based Compensation granted, vested or paid to a person who served as an Executive Officer at any time during the performance period for the Incentive-Based Compensation and that was Received: (i) on or after the Effective Date; (ii) after the person became an Executive Officer; (iii) while the Company has a class of securities listed on a national securities exchange or a national securities association; and (iv) during the three completed fiscal years immediately preceding the date that the Company is required to prepare a Restatement, including any applicable transition period that results from a change in the Company’s fiscal year within or immediately following those three completed fiscal years.
b)Erroneously Awarded Compensation” means the amount of Covered Compensation granted, vested or paid to a person during the fiscal period when the applicable Financial Reporting Measure relating to such Covered Compensation was attained that exceeds the amount of Covered Compensation that otherwise would have been granted, vested or paid to the person had such amount been determined based on the applicable Restatement, computed on a pre-tax basis. If the Committee cannot determine the amount of Erroneously Awarded Compensation directly from the information in the Restatement, the Committee will make a determination based on a reasonable estimate of the effect of the Restatement.
c)Executive Officer means the Company’s current and former executive officers, as determined by the Committee in accordance with Section 10D of the Exchange Act and the Nasdaq listing standards, and such other employees who may from time to time be deemed subject to the Policy by the Committee. As of the Effective Date, the Committee has determined that members of the Company’s Management Team and the Chief Accounting Officer are Executive Officers for purposes of this Policy.
d)Financial Reporting Measure” means (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures; (ii) stock price; or (iii) total shareholder return.
e)Incentive-Based Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure. Incentive-Based Compensation currently includes cash bonus awards under the CME Group Annual Incentive Plan and performance share awards under the CME Group Omnibus Stock Plan. Incentive-Based Compensation is deemed “Received” in the Company’s fiscal period during which the Financial Reporting Measure specified in or otherwise relating to the Incentive-Based Compensation award is attained, even if the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.
f)Restatement” means a required accounting restatement of any Company financial statement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including (i) to correct an error in previously issued
1



financial statements that is material to the previously issued financial statements (commonly referred to as a “Big R” restatement) or (ii) to correct an error in previously issued financial statements that is not material to the previously issued financial statements but that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (commonly referred to as a “little r” restatement). Changes to the Company’s financial statements that do not represent error corrections under the then-current relevant accounting standards will not constitute Restatements. Recovery of any Erroneously Awarded Compensation under the Policy is not dependent on fraud or misconduct by any person in connection with the Restatement.
2.Recoupment of Erroneously Awarded Compensation
In the event of a Restatement, the Company shall recover reasonably promptly any Erroneously Awarded Compensation unless the Committee determines that such recovery would be impracticable as defined by Rule 10D-1 of the Exchange Act and the Nasdaq listing standards.
The Committee will determine, in its sole discretion, the method for recovering any Erroneously Awarded Compensation including, without limitation: (i) reimbursement of cash Incentive Compensation previously paid; (ii) recovery of any gain realized on the vesting, exercise, settlement, sale, transfer or other disposition of any equity-based awards; (iii) offset against any compensation otherwise owed by the Company; (iv) cancellation or forfeiture of outstanding vested or unvested equity awards; and/or (v) any other remedial and recovery action permitted by law.
3.No Indemnification
The Company shall not indemnify any person against the loss of any Erroneously Awarded Compensation.
4.Miscellaneous
This Policy generally will be administered and interpreted by the Committee, provided that the Board may, from time to time, exercise discretion to administer and interpret this Policy, in which case, all references herein to “Committee” shall be deemed to refer to the Board. Any determination by the Committee with respect to this Policy shall be final, conclusive and binding on all interested parties. Any discretionary determinations of the Committee under this Policy, if any, need not be uniform with respect to all persons, and may be made selectively amongst persons, whether or not such persons are similarly situated.
It is intended that this Policy be interpreted in a manner that is consistent with the requirements of Section 10D of the Exchange Act and any applicable rules or standards adopted by the Securities and Exchange Commission or the Nasdaq, including any additional or new requirements that become effective after the Effective Date which upon effectiveness shall be deemed to automatically amend this Policy to the extent necessary to comply with such additional or new requirements.
The rights of the Company under this Policy to seek forfeiture or reimbursement are in addition to, and not in lieu of, any rights of recoupment, or remedies or rights other than recoupment, that may be available to the Company pursuant to the terms of any law, government regulation or stock exchange listing requirement or any other policy, code of conduct, employee handbook, employment agreement, equity award agreement, or other plan or agreement of the Company.
Each Executive Officer shall sign and return to the Company the Acknowledgement Form attached hereto as Exhibit A, pursuant to which the Executive Officer agrees to be bound by, and to comply with, the terms and conditions of this Policy.
2



5.Amendment and Termination
To the extent permitted by, and in a manner consistent with applicable law, including the rules and standards adopted by the Securities and Exchange Commission and the Nasdaq, the Committee may terminate, suspend or amend this Policy at any time in its discretion.
6.Successors
This Policy shall be binding and enforceable against all persons and their respective beneficiaries, heirs, executors, administrators or other legal representatives with respect to any Covered Compensation granted, vested or paid to or administered by such persons or entities.
3


EXHIBIT 97.1
EXHIBIT A

CME GROUP INC.
COMPENSATION RECOUPMENT POLICY
FOR EXECUTIVE OFFICERS

ACKNOWLEDGMENT, CONSENT AND AGREEMENT
I acknowledge that I have received and reviewed a copy of the CME Group Inc. Compensation Recoupment Policy for Executive Officers (the “Policy”) and I have been given an opportunity to ask questions about the Policy and review it with my counsel. I knowingly, voluntarily and irrevocably consent to and agree to be bound by and subject to the Policy’s terms and conditions, including that I will return any Erroneously Awarded Compensation that is required to be repaid in accordance with the Policy. I further acknowledge, understand and agree that (i) the compensation that I receive, have received or may become entitled to receive from the Company is subject to the Policy, and the Policy may affect such compensation and (ii) I have no right to indemnification, insurance payments or other reimbursement by or from the Company Group for any compensation that is subject to recoupment and/or forfeiture under the Policy.

Signed:            _________________________________________
Print Name:     _________________________________________
Date:                _________________________________________




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/28/24
For Period end:12/31/234
10/2/23
 List all Filings 


24 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/06/23  CME Group Inc.                    8-K:5,9    12/06/23   11:239K                                   Donnelley … Solutions/FA
11/13/23  CME Group Inc.                    8-K:5,9    11/07/23   12:261K                                   Donnelley … Solutions/FA
11/01/23  CME Group Inc.                    10-Q        9/30/23   64:6.4M
 4/28/23  CME Group Inc.                    8-K:1,2,9   4/26/23   11:1M                                     Donnelley … Solutions/FA
 3/30/23  CME Group Inc.                    8-K:5,9     3/29/23   12:276K                                   Donnelley … Solutions/FA
 3/10/23  CME Group Inc.                    8-K:5,9     3/06/23   11:257K                                   Donnelley … Solutions/FA
12/09/22  CME Group Inc.                    8-K:5,9    12/07/22   11:318K                                   Donnelley … Solutions/FA
 8/03/22  CME Group Inc.                    10-Q        6/30/22   69:8.1M
 6/09/22  CME Group Inc.                    S-8         6/09/22    6:158K                                   Donnelley … Solutions/FA
 4/28/22  CME Group Inc.                    8-K:1,2,9   4/28/22   11:1M                                     Donnelley … Solutions/FA
 3/08/22  CME Group Inc.                    8-K:1,2,9   3/08/22   12:330K                                   Donnelley … Solutions/FA
 2/25/22  CME Group Inc.                    10-K       12/31/21  108:12M
11/16/21  CME Group Inc.                    8-K:1,2,9  11/12/21   11:1M                                     Donnelley … Solutions/FA
11/04/21  CME Group Inc.                    8-K:3,5,7,911/04/21   13:438K                                   Donnelley … Solutions/FA
11/03/21  CME Group Inc.                    10-Q        9/30/21   67:7.4M
 4/29/21  CME Group Inc.                    8-K:1,2,9   4/28/21   11:1M                                     Donnelley … Solutions/FA
 6/21/18  CME Group Inc.                    8-K:1,2,9   6/21/18    5:310K                                   Donnelley … Solutions/FA
 3/01/18  CME Group Inc.                    10-K       12/31/17  112:11M
 3/09/15  CME Group Inc.                    8-K:1,2,8,9 3/04/15    4:307K                                   Donnelley … Solutions/FA
 2/26/15  CME Group Inc.                    10-K       12/31/14  126:18M
 9/09/13  CME Group Inc.                    8-K:1,2,9   9/04/13    5:319K                                   Donnelley … Solutions/FA
 3/02/09  CME Group Inc.                    10-K12/31/08   17:2.2M                                   Donnelley … Solutions/FA
 8/13/08  CME Group Inc.                    8-K:1,9     8/07/08    6:873K                                   Donnelley … Solutions/FA
 3/29/01  Nymex Holdings Inc.               10-K       12/31/00    6:311K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001156375-24-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 12:55:50.2am ET